Lineage Cell Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $142.6M
Liabilities Breakdown FY2016
Total Liabilities: $12.1M
Asset Breakdown
Total Assets: $142.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $22.1M | 15.5% |
| Accounts Receivable | $344.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.5M | 3.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $10.2M | 7.2% |
| Other Assets | $104.4M | 73.2% |
Liabilities Breakdown
Total Liabilities: $12.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.6M | 13.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.5M | 86.8% |